↓ Skip to main content

Cochrane Database of Systematic Reviews

Pimozide for tics in Tourette's syndrome

Overview of attention for article published in Cochrane database of systematic reviews, April 2009
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
wikipedia
1 Wikipedia page

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
89 Mendeley
Title
Pimozide for tics in Tourette's syndrome
Published in
Cochrane database of systematic reviews, April 2009
DOI 10.1002/14651858.cd006996.pub2
Pubmed ID
Authors

Tamara Pringsheim, Connie Marras

Abstract

Neuroleptic drugs with potent D-2 receptor blocking properties have been the traditional treatment for tics caused by Tourette Syndrome. Pimozide is the most studied of these. Use of these medications is declining because of concerns about side effects, and new atypical neuroleptics are now available. The true benefit and risks associated with pimozide compared to other drugs is not known.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Canada 1 1%
Unknown 86 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 20%
Researcher 9 10%
Student > Bachelor 8 9%
Student > Postgraduate 6 7%
Other 6 7%
Other 16 18%
Unknown 26 29%
Readers by discipline Count As %
Medicine and Dentistry 28 31%
Psychology 11 12%
Nursing and Health Professions 7 8%
Biochemistry, Genetics and Molecular Biology 4 4%
Agricultural and Biological Sciences 3 3%
Other 10 11%
Unknown 26 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2013.
All research outputs
#5,961,455
of 19,701,123 outputs
Outputs from Cochrane database of systematic reviews
#8,094
of 11,953 outputs
Outputs of similar age
#39,562
of 129,010 outputs
Outputs of similar age from Cochrane database of systematic reviews
#47
of 76 outputs
Altmetric has tracked 19,701,123 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 11,953 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.7. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 129,010 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.